CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
Kymera Therapeutics (NASDAQ: KYMR) is a biotechnology company that develops an approach to treating previously untreatable diseases. Kymera aims to accelerate drug discovery with an ability to target and degrade proteins and advance treatment options...Show all
Company (IPO / Went public)
Phone: 857-285-5314
300 Technology Square
2nd Floor
Cambridge, 02139
Massachusetts, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Irak degraders and uses thereof | Dec 21, 2018 | Dec 29, 2020 | Patent |
| Tricyclic crbn ligands and uses thereof | Jul 03, 2019 | Application | |
| Crbn ligands and uses thereof | Jan 14, 2019 | Application | |
| Protein degraders and uses thereof | Jan 14, 2019 | Application | |
| Crbn ligands and uses thereof | Sep 21, 2018 | Application |
